Prescribing in palliative care A quest for appropriateness

Abstract

Get full access to this article

View all access options for this article.

References

Neubert

Dormann

Weiss

. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 1059–1067.

Pavis

Wilcock

. Prescribing of drugs for use outside their licence in palliative care: survey of specialists in the United Kingdom. BMJ 2001; 323: 484–485.

Atkinson

Kirkham

. Unlicensed uses for medication in a palliative care unit. Palliat Med 1999; 13: 145–152.

Toscani

Di Giulio

Campi

.; End of Life Observatory Research Group. Off-label prescriptions in Italian hospices: a national survey. J Pain Symptom Manage 2009; 38: 365–371.

Chen

Wynia

Moloney

. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf 2009; 18: 1094–10100.

Culshaw

Kendall

Wilcock

. Off-label prescribing in palliative care: A survey of independent prescribers. Palliat Med 2013; 27: 314–319.

THM

Agar

Shelby-James

. Off-label prescribing in palliative care - a cross-sectional national survey of Palliative Medicine doctors. Palliat Med 2013; 27: 320–328.

Holmes

Hayley

Alexander

. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605–609.